| Autor |
Wiadomość |
| Aibolid |
 Wysłany: Wto 18:41, 29 Sie 2006 Temat postu: Usefull Info |
|
Zolpidem is a prescription drug used for the short-term treatment of insomnia (sleeping pill). It works quickly (usually within 15 minutes) and has a short half-life (2-3 hours), but will last longer in patients with hepatic failure. Some trade names of zolpidem are AmbienR, StilnoxR, StilnoctR, or MysleeR.[1] Its sedative effects are similar to those of the benzodiazepines, but it is actually classified as an [URL=http://dic.blogopt.c
om/imidazopyridine]imidazopyridine[/URL], and the anticonvulsant and muscle relaxant effects only appear at 10 and 20 times the dose required for sedation, respectively.[2] For that reason, it has never been approved for either muscle relaxation or seizure prevention. Such drastically increased doses are likely to induce one or more negative side effects, including hallucinations and/or amnesia. The patent on zolpidem is held by the French pharmacutical corporation Sanofi-Aventis.Larger doses of the drug can result in a variety of unwanted side effects: hallucinations, delusions, poor motor coordination, euphoria (though many instead report dysphoric reactions) increased appeti
te, increased sex drive, poor judgement, and, following use, inability to remember events that took place while under the influence of the drug (anterograde amnesia). Some users take zolpidem recreationally for these side effects, however, it is not as common as with the benzodiazepines because of its unique mental imagery (which can distract the user from reality without actually producing genuine hallucinations) and irrational behaviour combined with the amnesia. Accordingly, Zolpidem can also become psychologically addictive if taken for extended periods of time, due to dependence on its ability to put one to sleep or to the unique sense of euphoria it can produce. Under the influence of the drug it is common to take more zolpidem than is necessary due to forgetting that one has already taken a pill. Us
ers are advised to keep additional zolpidem away to avoid this risk. |
|
|
